IBDEI16K ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19729,0)
 ;;=R64.^^94^928^46
 ;;^UTILITY(U,$J,358.3,19729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19729,1,3,0)
 ;;=3^Cachexia
 ;;^UTILITY(U,$J,358.3,19729,1,4,0)
 ;;=4^R64.
 ;;^UTILITY(U,$J,358.3,19729,2)
 ;;=^17920
 ;;^UTILITY(U,$J,358.3,19730,0)
 ;;=R68.3^^94^928^51
 ;;^UTILITY(U,$J,358.3,19730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19730,1,3,0)
 ;;=3^Clubbing of Fingers
 ;;^UTILITY(U,$J,358.3,19730,1,4,0)
 ;;=4^R68.3
 ;;^UTILITY(U,$J,358.3,19730,2)
 ;;=^5019553
 ;;^UTILITY(U,$J,358.3,19731,0)
 ;;=R73.01^^94^928^89
 ;;^UTILITY(U,$J,358.3,19731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19731,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,19731,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,19731,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,19732,0)
 ;;=R73.02^^94^928^90
 ;;^UTILITY(U,$J,358.3,19732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19732,1,3,0)
 ;;=3^Impaired Glucose Tolerance (oral)
 ;;^UTILITY(U,$J,358.3,19732,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,19732,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,19733,0)
 ;;=R73.09^^94^928^15
 ;;^UTILITY(U,$J,358.3,19733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19733,1,3,0)
 ;;=3^Abnormal Glucose NEC
 ;;^UTILITY(U,$J,358.3,19733,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,19733,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,19734,0)
 ;;=R73.9^^94^928^84
 ;;^UTILITY(U,$J,358.3,19734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19734,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,19734,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,19734,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,19735,0)
 ;;=R76.11^^94^928^142
 ;;^UTILITY(U,$J,358.3,19735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19735,1,3,0)
 ;;=3^Positive PPD
 ;;^UTILITY(U,$J,358.3,19735,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,19735,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,19736,0)
 ;;=R79.1^^94^928^3
 ;;^UTILITY(U,$J,358.3,19736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19736,1,3,0)
 ;;=3^Abnormal Coagulation Profile
 ;;^UTILITY(U,$J,358.3,19736,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,19736,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,19737,0)
 ;;=R82.5^^94^928^69
 ;;^UTILITY(U,$J,358.3,19737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19737,1,3,0)
 ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
 ;;^UTILITY(U,$J,358.3,19737,1,4,0)
 ;;=4^R82.5
 ;;^UTILITY(U,$J,358.3,19737,2)
 ;;=^5019605
 ;;^UTILITY(U,$J,358.3,19738,0)
 ;;=R82.6^^94^928^26
 ;;^UTILITY(U,$J,358.3,19738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19738,1,3,0)
 ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
 ;;^UTILITY(U,$J,358.3,19738,1,4,0)
 ;;=4^R82.6
 ;;^UTILITY(U,$J,358.3,19738,2)
 ;;=^5019606
 ;;^UTILITY(U,$J,358.3,19739,0)
 ;;=R82.7^^94^928^27
 ;;^UTILITY(U,$J,358.3,19739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19739,1,3,0)
 ;;=3^Abnormal Urine Microbiological Findings
 ;;^UTILITY(U,$J,358.3,19739,1,4,0)
 ;;=4^R82.7
 ;;^UTILITY(U,$J,358.3,19739,2)
 ;;=^5019607
 ;;^UTILITY(U,$J,358.3,19740,0)
 ;;=R82.8^^94^928^23
 ;;^UTILITY(U,$J,358.3,19740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19740,1,3,0)
 ;;=3^Abnormal Urine Cytology/Histology Findings
 ;;^UTILITY(U,$J,358.3,19740,1,4,0)
 ;;=4^R82.8
 ;;^UTILITY(U,$J,358.3,19740,2)
 ;;=^5019608
 ;;^UTILITY(U,$J,358.3,19741,0)
 ;;=R82.90^^94^928^25
 ;;^UTILITY(U,$J,358.3,19741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19741,1,3,0)
 ;;=3^Abnormal Urine Findings,Unspec
 ;;^UTILITY(U,$J,358.3,19741,1,4,0)
 ;;=4^R82.90
 ;;^UTILITY(U,$J,358.3,19741,2)
 ;;=^5019609
 ;;^UTILITY(U,$J,358.3,19742,0)
 ;;=R82.91^^94^928^49
 ;;^UTILITY(U,$J,358.3,19742,1,0)
 ;;=^358.31IA^4^2
